France Bed Holdings Co.,Ltd.

TSE:7840 Stock Report

Market Cap: JP¥45.8b

France Bed HoldingsLtd Past Earnings Performance

Past criteria checks 5/6

France Bed HoldingsLtd has been growing earnings at an average annual rate of 8.1%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 3.5% per year. France Bed HoldingsLtd's return on equity is 8.3%, and it has net margins of 5.3%.

Key information

8.1%

Earnings growth rate

10.4%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate3.5%
Return on equity8.3%
Net Margin5.3%
Next Earnings Update07 Feb 2025

Recent past performance updates

Recent updates

France Bed HoldingsLtd (TSE:7840) Is Due To Pay A Dividend Of ¥22.00

Dec 25
France Bed HoldingsLtd (TSE:7840) Is Due To Pay A Dividend Of ¥22.00

France Bed HoldingsLtd (TSE:7840) Is Due To Pay A Dividend Of ¥22.00

Dec 06
France Bed HoldingsLtd (TSE:7840) Is Due To Pay A Dividend Of ¥22.00

France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

Mar 11
France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Feb 26
France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Revenue & Expenses Breakdown

How France Bed HoldingsLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:7840 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2460,0353,21027,8250
30 Jun 2459,9973,17127,6140
31 Mar 2459,1513,13427,3020
31 Dec 2358,7052,63627,2880
30 Sep 2358,7002,71227,0930
30 Jun 2358,7822,77426,8610
31 Mar 2358,5782,70226,7130
31 Dec 2257,5542,54426,3930
30 Sep 2256,6642,49126,0210
30 Jun 2255,3922,34925,6450
31 Mar 2254,3982,55725,0810
31 Dec 2154,1132,62524,7630
30 Sep 2154,0102,74924,4990
30 Jun 2154,0512,77824,2900
31 Mar 2152,4302,29523,7920
31 Dec 2051,2051,95823,3020
30 Sep 2050,4991,70523,1180
30 Jun 2051,1941,54523,1180
31 Mar 2052,4301,52023,4250
31 Dec 1952,7552,91023,4930
30 Sep 1952,7972,57623,4130
30 Jun 1951,6462,42523,2640
31 Mar 1951,7642,59923,1280
31 Dec 1852,3331,57923,1330
30 Sep 1852,2071,74423,0280
30 Jun 1852,5291,90022,9220
31 Mar 1852,4101,80622,8280
31 Dec 1752,3062,20022,7900
30 Sep 1752,2412,09722,8590
30 Jun 1752,0511,88722,7980
31 Mar 1752,1261,93122,7560
31 Dec 1652,0081,20222,7030
30 Sep 1652,3771,33122,5640
30 Jun 1652,5491,38422,4400
31 Mar 1652,6441,40222,3100
31 Dec 1552,8601,36422,1950
30 Sep 1552,6091,18822,1920
30 Jun 1552,0771,03322,2410
31 Mar 1551,90790422,2910
31 Dec 1453,4221,00422,3960
30 Sep 1454,2031,14322,3040
30 Jun 1454,6081,31522,0730
31 Mar 1454,8911,39721,9390
31 Dec 1352,7281,28821,4790

Quality Earnings: 7840 has high quality earnings.

Growing Profit Margin: 7840's current net profit margins (5.3%) are higher than last year (4.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 7840's earnings have grown by 8.1% per year over the past 5 years.

Accelerating Growth: 7840's earnings growth over the past year (18.4%) exceeds its 5-year average (8.1% per year).

Earnings vs Industry: 7840 earnings growth over the past year (18.4%) exceeded the Healthcare industry 8.3%.

Return on Equity

High ROE: 7840's Return on Equity (8.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 08:11
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

France Bed Holdings Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Masatoshi NagataIchiyoshi Research Institute Inc.
Vipin GanwirVirtua Research Inc.